Report cover image

Global Oral Polio Vaccines (OPV) Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 97 Pages
SKU # APRC20549094

Description

Summary

According to APO Research, The global Oral Polio Vaccines (OPV) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Oral Polio Vaccines (OPV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Oral Polio Vaccines (OPV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Oral Polio Vaccines (OPV) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Oral Polio Vaccines (OPV) include Sanofi, GSK, Tiantan Biological, Serum Institute, Panacea Biotec Ltd, IMBCA, Halfkin Bio-Pharmaceuticals, Bio-Med and Bibcol, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Polio Vaccines (OPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Polio Vaccines (OPV).
The Oral Polio Vaccines (OPV) market size, estimations, and forecasts are provided in terms of sales volume (k doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Polio Vaccines (OPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Oral Polio Vaccines (OPV) Segment by Company

Sanofi
GSK
Tiantan Biological
Serum Institute
Panacea Biotec Ltd
IMBCA
Halfkin Bio-Pharmaceuticals
Bio-Med
Bibcol
Oral Polio Vaccines (OPV) Segment by Type

Trivalent OPV
Bivalent OPV
Oral Polio Vaccines (OPV) Segment by Application

Public
Private
Oral Polio Vaccines (OPV) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Polio Vaccines (OPV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Polio Vaccines (OPV) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Polio Vaccines (OPV).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Polio Vaccines (OPV) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Polio Vaccines (OPV) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

97 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Polio Vaccines (OPV) Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Oral Polio Vaccines (OPV) Sales Estimates and Forecasts (2020-2031)
1.3 Oral Polio Vaccines (OPV) Market by Type
1.3.1 Trivalent OPV
1.3.2 Bivalent OPV
1.4 Global Oral Polio Vaccines (OPV) Market Size by Type
1.4.1 Global Oral Polio Vaccines (OPV) Market Size Overview by Type (2020-2031)
1.4.2 Global Oral Polio Vaccines (OPV) Historic Market Size Review by Type (2020-2025)
1.4.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Oral Polio Vaccines (OPV) Sales Breakdown by Type (2020-2025)
1.5.2 Europe Oral Polio Vaccines (OPV) Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Breakdown by Type (2020-2025)
1.5.4 South America Oral Polio Vaccines (OPV) Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Oral Polio Vaccines (OPV) Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Oral Polio Vaccines (OPV) Industry Trends
2.2 Oral Polio Vaccines (OPV) Industry Drivers
2.3 Oral Polio Vaccines (OPV) Industry Opportunities and Challenges
2.4 Oral Polio Vaccines (OPV) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Oral Polio Vaccines (OPV) Revenue (2020-2025)
3.2 Global Top Players by Oral Polio Vaccines (OPV) Sales (2020-2025)
3.3 Global Top Players by Oral Polio Vaccines (OPV) Price (2020-2025)
3.4 Global Oral Polio Vaccines (OPV) Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral Polio Vaccines (OPV) Major Company Production Sites & Headquarters
3.6 Global Oral Polio Vaccines (OPV) Company, Product Type & Application
3.7 Global Oral Polio Vaccines (OPV) Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral Polio Vaccines (OPV) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Polio Vaccines (OPV) Players Market Share by Revenue in 2024
3.8.3 2023 Oral Polio Vaccines (OPV) Tier 1, Tier 2, and Tier 3
4 Oral Polio Vaccines (OPV) Regional Status and Outlook
4.1 Global Oral Polio Vaccines (OPV) Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Oral Polio Vaccines (OPV) Historic Market Size by Region
4.2.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2020-2025)
4.2.2 Global Oral Polio Vaccines (OPV) Sales in Value by Region (2020-2025)
4.2.3 Global Oral Polio Vaccines (OPV) Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Region
4.3.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2026-2031)
4.3.2 Global Oral Polio Vaccines (OPV) Sales in Value by Region (2026-2031)
4.3.3 Global Oral Polio Vaccines (OPV) Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Oral Polio Vaccines (OPV) by Application
5.1 Oral Polio Vaccines (OPV) Market by Application
5.1.1 Public
5.1.2 Private
5.2 Global Oral Polio Vaccines (OPV) Market Size by Application
5.2.1 Global Oral Polio Vaccines (OPV) Market Size Overview by Application (2020-2031)
5.2.2 Global Oral Polio Vaccines (OPV) Historic Market Size Review by Application (2020-2025)
5.2.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Oral Polio Vaccines (OPV) Sales Breakdown by Application (2020-2025)
5.3.2 Europe Oral Polio Vaccines (OPV) Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Breakdown by Application (2020-2025)
5.3.4 South America Oral Polio Vaccines (OPV) Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Oral Polio Vaccines (OPV) Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Sanofi
6.1.1 Sanofi Comapny Information
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio
6.1.5 Sanofi Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio
6.2.5 GSK Recent Developments
6.3 Tiantan Biological
6.3.1 Tiantan Biological Comapny Information
6.3.2 Tiantan Biological Business Overview
6.3.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio
6.3.5 Tiantan Biological Recent Developments
6.4 Serum Institute
6.4.1 Serum Institute Comapny Information
6.4.2 Serum Institute Business Overview
6.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio
6.4.5 Serum Institute Recent Developments
6.5 Panacea Biotec Ltd
6.5.1 Panacea Biotec Ltd Comapny Information
6.5.2 Panacea Biotec Ltd Business Overview
6.5.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio
6.5.5 Panacea Biotec Ltd Recent Developments
6.6 IMBCA
6.6.1 IMBCA Comapny Information
6.6.2 IMBCA Business Overview
6.6.3 IMBCA Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 IMBCA Oral Polio Vaccines (OPV) Product Portfolio
6.6.5 IMBCA Recent Developments
6.7 Halfkin Bio-Pharmaceuticals
6.7.1 Halfkin Bio-Pharmaceuticals Comapny Information
6.7.2 Halfkin Bio-Pharmaceuticals Business Overview
6.7.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio
6.7.5 Halfkin Bio-Pharmaceuticals Recent Developments
6.8 Bio-Med
6.8.1 Bio-Med Comapny Information
6.8.2 Bio-Med Business Overview
6.8.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio
6.8.5 Bio-Med Recent Developments
6.9 Bibcol
6.9.1 Bibcol Comapny Information
6.9.2 Bibcol Business Overview
6.9.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio
6.9.5 Bibcol Recent Developments
7 North America by Country
7.1 North America Oral Polio Vaccines (OPV) Sales by Country
7.1.1 North America Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Oral Polio Vaccines (OPV) Sales by Country (2020-2025)
7.1.3 North America Oral Polio Vaccines (OPV) Sales Forecast by Country (2026-2031)
7.2 North America Oral Polio Vaccines (OPV) Market Size by Country
7.2.1 North America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Oral Polio Vaccines (OPV) Market Size by Country (2020-2025)
7.2.3 North America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Oral Polio Vaccines (OPV) Sales by Country
8.1.1 Europe Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Oral Polio Vaccines (OPV) Sales by Country (2020-2025)
8.1.3 Europe Oral Polio Vaccines (OPV) Sales Forecast by Country (2026-2031)
8.2 Europe Oral Polio Vaccines (OPV) Market Size by Country
8.2.1 Europe Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Oral Polio Vaccines (OPV) Market Size by Country (2020-2025)
8.2.3 Europe Oral Polio Vaccines (OPV) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country
9.1.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country (2020-2025)
9.1.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country
9.2.1 Asia-Pacific Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Oral Polio Vaccines (OPV) Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Oral Polio Vaccines (OPV) Sales by Country
10.1.1 South America Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Oral Polio Vaccines (OPV) Sales by Country (2020-2025)
10.1.3 South America Oral Polio Vaccines (OPV) Sales Forecast by Country (2026-2031)
10.2 South America Oral Polio Vaccines (OPV) Market Size by Country
10.2.1 South America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Oral Polio Vaccines (OPV) Market Size by Country (2020-2025)
10.2.3 South America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country
11.1.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2020-2025)
11.1.3 Middle East and Africa Oral Polio Vaccines (OPV) Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country
11.2.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Oral Polio Vaccines (OPV) Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Oral Polio Vaccines (OPV) Value Chain Analysis
12.1.1 Oral Polio Vaccines (OPV) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oral Polio Vaccines (OPV) Production Mode & Process
12.2 Oral Polio Vaccines (OPV) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oral Polio Vaccines (OPV) Distributors
12.2.3 Oral Polio Vaccines (OPV) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.